| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-811 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
1992-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e595c21111a76ac06e122fcf48e7083a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0daf759845ca7b34cdffae313df0845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e5e739e875f91fd3ea48c6cb1e0435c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04e10fc113e404d3c4e53711d5b1241c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdbeadd0798178afecfb3142b334cbad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_818000bee44d76d0163c01eca35b67b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cb40cc828db1febc60661dd97b41bb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ae95b2cf2b46756a75cd153c405919e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_568769f928bb6fbcafd3b227e231fc20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6280bb0243c74a5ae077bae578a1c64 |
| publicationDate |
1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5851983-A |
| titleOfInvention |
Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology |
| abstract |
The present invention provides an elastase inhibitory polypeptide comprising a C-terminal half of a human secretory leukocyte protease inhibitor (SLPI) and having an elastase inhibitory activity wherein inhibitory activity of a trypsin-like serine protease does not exceed +E,fra 1/10+EE of elastase inhibitory activity, and polypeptides having the above-mentioned biological activity wherein one or more than one amino acid is added, one or more than one amino acid is deleted and/or one or more than one amino acid is replaced. The present invention also provides a process for the production of the above-mentioned protein or other protein via a corresponding fused protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7709446-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10101792-B4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7933722-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8252905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008085854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005202527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008286290-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291662-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006269946-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006275808-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008181892-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011182872-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03035861-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2831170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007099202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03035861-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7247704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7589178-B2 |
| priorityDate |
1987-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |